Artificial intelligence (AI) has become a strategic frontier shaping national competitiveness and redefining the financial foundations of technological transformation. Yet the governance mechanisms through which patient capital supports firms’ strategic commitment to AI remain insufficiently understood. Using data on Chinese A-share listed firms from 2007 to 2023, this study constructs an AI strategy expression indicator and empirically evaluates the impact of patient capital on firms’ AI orientation. The findings show that patient capital significantly strengthens AI strategy, underscoring its governance value in high uncertainty and long horizon investment. Mechanism analysis further demonstrates that patient capital fosters long-termism, reduces agency costs, and improves the information environment, thereby enhancing firms’ strategic allocation in complex technologies. This study highlights the governance function of patient capital in intelligent transformation and provides evidence for the coordinated evolution of AI-driven technological upgrading and capital governance in emerging markets.
扫码关注我们
求助内容:
应助结果提醒方式:
